Top Premarket Gainers

MT Newswires Live10-14

Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment candidate for metabolic dysfunction-associated steatohepatitis.

Expion360 (XPON) stock was 57% higher following a 3.9% gain in the previous session.

Longboard Pharmaceuticals (LBPH) shares were up 51% after the company said it agreed to be acquired by Lundbeck in a deal valued at $2.60 billion.

Jasper Therapeutics (JSPR) stock was 26% higher after the company reported that 14 of 15 patients enrolled in both dose cohorts of its phase 1b/2a trial of a treatment candidate for chronic inducible urticaria achieved a clinical response.

B. Riley Financial (RILY) shares were up nearly 23% after the company said it has agreed to sell its Great American Group unit to Oaktree in a deal valued at $386 million.

Price: 3.1300, Change: +1.24, Percent Change: +65.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2475836820?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-14 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2475836820","market":"us","top_or_hot":-1,"title":"Top Premarket Gainers","media":"MT Newswires Live","content":"<html><body><p> Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment candidate for metabolic dysfunction-associated steatohepatitis.</p><p>Expion360 (XPON) stock was 57% higher following a 3.9% gain in the previous session.</p><p>Longboard Pharmaceuticals (LBPH) shares were up 51% after the company said it agreed to be acquired by Lundbeck in a deal valued at $2.60 billion.</p><p><a href=\"https://laohu8.com/S/JSPR\">Jasper Therapeutics</a> (JSPR) stock was 26% higher after the company reported that 14 of 15 patients enrolled in both dose cohorts of its phase 1b/2a trial of a treatment candidate for chronic inducible urticaria achieved a clinical response.</p><p>B. Riley Financial (RILY) shares were up nearly 23% after the company said it has agreed to sell its Great American Group unit to Oaktree in a deal valued at $386 million.</p><p>Price: 3.1300, Change: +1.24, Percent Change: +65.61</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-14 19:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4127","symbol_name":"投资银行业与经纪业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2475836820","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2475836820","pubTimestamp":1728907081,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4127":"投资银行业与经纪业","LBPH":"Longboard Pharmaceuticals, Inc.","IE0031619046.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) INC","XPON":"Expion360 Inc.","IE00B66KJ199.SGD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY  \" A\" (SGD) ACC","BK4096":"电气部件与设备","BK4139":"生物科技","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","RILY":"B. Riley Financial, Inc.","BK4007":"制药","IVA":"Inventiva S.A.","JSPR":"Jasper Therapeutics","IE00B19Z4B17.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC"},"translate_title":"盘前涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IVA":0.9,"JSPR":0.9,"LBPH":0.9,"RILY":0.9,"XPON":0.9},"content_text":"Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment candidate for metabolic dysfunction-associated steatohepatitis.Expion360 (XPON) stock was 57% higher following a 3.9% gain in the previous session.Longboard Pharmaceuticals (LBPH) shares were up 51% after the company said it agreed to be acquired by Lundbeck in a deal valued at $2.60 billion.Jasper Therapeutics (JSPR) stock was 26% higher after the company reported that 14 of 15 patients enrolled in both dose cohorts of its phase 1b/2a trial of a treatment candidate for chronic inducible urticaria achieved a clinical response.B. Riley Financial (RILY) shares were up nearly 23% after the company said it has agreed to sell its Great American Group unit to Oaktree in a deal valued at $386 million.Price: 3.1300, Change: +1.24, Percent Change: +65.61","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2475836820"}